Bluejay Therapeutics Appoints Mary Cromwell as Senior Vice President and Head of Technical Operations
REDWOOD CITY, Calif., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Bluejay Therapeutics, a clinical-stage biopharmaceutical company dedicated to developing potentially life-changing therapeutics for serious viral and liver diseases, today announced that Mary Cromwell, Ph.D., has joined its leadership team as Senior Vice President and Head of Technical Operations.
"Mary is a seasoned biotech executive with a track record of exceptional leadership in manufacturing sciences, formulation, quality, supply chain management, process development and BLA submissions. She has played key roles in advancing therapeutic candidates from late-stage research through commercialization,' said Keting Chu, M.D., Ph.D., Founder and Chief Executive Officer of Bluejay Therapeutics. 'I am thrilled to welcome her to Bluejay Therapeutics as we continue our efforts to advance new therapeutic options for people living with chronic hepatitis D and chronic hepatitis B.'
Dr. Cromwell has more than 30 years of experience in biotechnology operations and technical leadership. Most recently, she was Chief Technology Officer at Allakos, where she led technical operations and manufacturing strategy. Prior to that, Dr. Cromwell held a series of positions of increasing responsibility at Genentech/Roche, including Vice President and Head of Quality, Drug Substance, overseeing Quality Assurance and Quality Control for manufacturing. Her expertise spans end-to-end process and product technical development, quality and manufacturing. She was directly involved in the licensure of numerous Genentech/Roche products, including Avastin® and Perjeta® and served as a member of the Genentech Foundation Board. Dr. Cromwell holds a Ph.D. from the University of Colorado, Denver, a master's degree in biophysical chemistry from the University of California, Berkeley, and a bachelor's degree in chemistry from West Virginia University.
Bluejay's lead product candidate brelovitug (BJT-778) recently received U.S. Food and Drug Administration (FDA) Breakthrough Therapy designation for the treatment of chronic hepatitis delta (CHD). Brelovitug also previously received EMA's PRIME and Orphan designation.
About Bluejay TherapeuticsBluejay Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing potentially life-changing therapeutics for serious viral and liver diseases. The company is currently investigating brelovitug (BJT-778) for the treatment of chronic hepatitis D (CHD) and chronic hepatitis B (CHB) virus infections. Additionally, Bluejay is advancing several innovative programs with the goal of developing a combination regimen to achieve a functional cure for chronic hepatitis B, including a proprietary TLR9 agonist (cavrotolimod) and a liver-targeted hepatitis B virus (HBV) transcript inhibitor (BJT-628). For more information on Bluejay Therapeutics, please visit the company's website at www.bluejaytx.com or follow the company on LinkedIn.
Media Contact: Dan Boyle Orangefiery media@orangefiery.com 818-209-1692
Investor Contact: Peter GarciaCFO, Bluejay Therapeuticsir@bluejaytx.com650-674-2480Sign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
Samsara to Host Investor Day on June 24th, 2025
SAN FRANCISCO, June 09, 2025--(BUSINESS WIRE)--Samsara Inc. ("Samsara") (NYSE: IOT), the pioneer of the Connected Operations® Platform, today announced that it will host its Investor Day on June 24th, 2025 from 2:30 - 5:00 p.m. Pacific Time (5:30 - 8:00 p.m. Eastern Time). Members of Samsara's executive leadership team, including Sanjit Biswas (CEO and Co-Founder), Kiren Sekar (Chief Product Officer), Amit Vyas (Chief Revenue Officer), and Dominic Phillips (Chief Financial Officer) will discuss updates to the company's vision, product platform, customer momentum, and financials. A live webcast will begin at 2:30 p.m. Pacific Time (5:30 p.m. Eastern Time) on June 24th, 2025. Registration for access to the webcast can be found at this link. A replay of the webcast will be available following the conclusion of the event at About Samsara Samsara (NYSE: IOT) is the pioneer of the Connected Operations® Platform, which enables organizations that depend on physical operations to harness Internet of Things (IoT) data to develop actionable insights and improve their operations. With tens of thousands of customers across North America and Europe, Samsara is a proud technology partner to the people who keep our global economy running, including the world's leading organizations across construction, transportation and warehousing, field services, manufacturing, retail, logistics, and the public sector. The company's mission is to increase the safety, efficiency, and sustainability of the operations that power the global economy. View source version on Contacts Investor ContactMike Changir@ Media ContactStephanie Burkemedia@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
27 minutes ago
- Business Wire
Samsara to Host Investor Day on June 24th, 2025
SAN FRANCISCO--(BUSINESS WIRE)-- Samsara Inc. ("Samsara") (NYSE: IOT), the pioneer of the Connected Operations ® Platform, today announced that it will host its Investor Day on June 24th, 2025 from 2:30 - 5:00 p.m. Pacific Time (5:30 - 8:00 p.m. Eastern Time). Members of Samsara's executive leadership team, including Sanjit Biswas (CEO and Co-Founder), Kiren Sekar (Chief Product Officer), Amit Vyas (Chief Revenue Officer), and Dominic Phillips (Chief Financial Officer) will discuss updates to the company's vision, product platform, customer momentum, and financials. A live webcast will begin at 2:30 p.m. Pacific Time (5:30 p.m. Eastern Time) on June 24th, 2025. Registration for access to the webcast can be found at this link. A replay of the webcast will be available following the conclusion of the event at About Samsara Samsara (NYSE: IOT) is the pioneer of the Connected Operations ® Platform, which enables organizations that depend on physical operations to harness Internet of Things (IoT) data to develop actionable insights and improve their operations. With tens of thousands of customers across North America and Europe, Samsara is a proud technology partner to the people who keep our global economy running, including the world's leading organizations across construction, transportation and warehousing, field services, manufacturing, retail, logistics, and the public sector. The company's mission is to increase the safety, efficiency, and sustainability of the operations that power the global economy.
Yahoo
32 minutes ago
- Yahoo
KB Home to Release 2025 Second Quarter Earnings on June 23, 2025
LOS ANGELES, June 09, 2025--(BUSINESS WIRE)--KB Home (NYSE: KBH) today announced that it will release earnings for its second quarter ended May 31, 2025 after the market closes on Monday, June 23, 2025. A live webcast of the Company's earnings conference call will be held the same day at 2:00 p.m. Pacific Time, 5:00 p.m. Eastern Time. To listen to the call, go to the Investor Relations section of the KB Home website at and select the Second Quarter Earnings Conference Call link in the Events and Presentations section. The webcast will be available for replay at the KB Home website for 30 days. About KB Home KB Home is one of the largest and most trusted homebuilders in the United States. We operate in 49 markets, have built nearly 700,000 quality homes in our more than 65-year history, and are honored to be the #1 customer-ranked national homebuilder based on third-party buyer surveys. What sets KB Home apart is building strong, personal relationships with every customer and creating an exceptional homebuying experience that offers our homebuyers the ability to personalize their home based on what they value at a price they can afford. As the industry leader in sustainability, KB Home has achieved one of the highest residential energy-efficiency ratings and delivered more ENERGY STAR® certified homes than any other builder, helping to lower the total cost of homeownership. For more information, visit View source version on Contacts For Further Information: Jill Peters, Investor Relations Contact(310) 893-7456 orinvestorrelations@
